News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

SCENESSE® applied under five-year Veterans Affairs contract

2023 Announcements.Corporate

26.07.2023

CLINUVEL secures IP for melanocortins to treat central nervous system disorders

2023 Announcements . Corporate

14.07.2023

Notification regarding unquoted securities

2023 Announcements . Financial . Regulatory

30.06.2023

Two grounds of Appeal upheld by NICE Panel

2023 Announcements . Clinical . Regulatory

30.06.2023

News Kommuniqué III

2023 Announcements . Corporate . Newsletter

30.06.2023

Notification of cessation of securities

2023 Announcements . Financial . Regulatory

29.06.2023

Twilight Event – Briefing

2023 Announcements . Corporate . News

29.06.2023

Change of Director’s Interest Notice

2023 Announcements . Financial . Regulatory

28.06.2023

News Communiqué III

2023 Announcements . Corporate . News

26.06.2023

Strategic Update VI

2023 Announcements . Corporate . Presentation

01.06.2023

CLINUVEL Bulletin Edition 01

2023 Announcements . Newsletter

31.05.2023

CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients

2023 Announcements . Clinical . News . Regulatory

09.05.2023

Expansion of CLINUVEL’s global porphyria programs

2023 Announcements . Clinical . Regulatory

01.05.2023

.

Go To Top